Literature DB >> 18057254

Replication of beta- and gammaretroviruses is restricted in I/LnJ mice via the same genetic mechanism.

Laure K Case1, Lydia Petell, Leonid Yurkovetskiy, Alexandra Purdy, Katherine J Savage, Tatyana V Golovkina.   

Abstract

Mice of the I/LnJ inbred strain are unique in their ability to mount a robust and sustained humoral immune response capable of neutralizing infection with a betaretrovirus, mouse mammary tumor virus (MMTV). Virus-neutralizing antibodies (Abs) coat MMTV virions secreted by infected cells, preventing virus spread and hence the formation of mammary tumors. To investigate whether I/LnJ mice resist infection with other retroviruses besides MMTV, the animals were infected with murine leukemia virus (MuLV), a gammaretrovirus. MuLV-infected I/LnJ mice produced virus-neutralizing Abs that block virus transmission and virally induced disease. Generation of virus-neutralizing Abs required gamma interferon but was independent of interleukin-12. This unique mechanism of retrovirus resistance is governed by a single recessive gene, virus infectivity controller 1 (vic1), mapped to chromosome 17. In addition to controlling the antivirus humoral immune response, vic1 is also required for an antiviral cytotoxic response. Both types of responses were maintained in mice of the susceptible genetic background but congenic for the I/LnJ vic1 locus. Although the vic1-mediated resistance to MuLV resembles the mechanism of retroviral recovery controlled by the resistance to Friend virus 3 (rfv3) gene, the rfv3 gene has been mapped to chromosome 15 and confers resistance to MuLV but not to MMTV. Thus, we have identified a unique virus resistance mechanism that controls immunity against two distinct retroviruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057254      PMCID: PMC2224426          DOI: 10.1128/JVI.01991-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Mice lacking IL-12 develop polarized Th1 cells during viral infection.

Authors:  V E Schijns; B L Haagmans; C M Wierda; B Kruithof; I A Heijnen; G Alber; M C Horzinek
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

Review 2.  Antigen presentation by CD1 and MHC-encoded class I-like molecules.

Authors:  A Melián; E M Beckman; S A Porcelli; M B Brenner
Journal:  Curr Opin Immunol       Date:  1996-02       Impact factor: 7.486

3.  Fine mapping of the friend retrovirus resistance gene, Rfv3, on mouse chromosome 15.

Authors:  H J Super; K J Hasenkrug; S Simmons; D M Brooks; R Konzek; K D Sarge; R I Morimoto; N A Jenkins; D J Gilbert; N G Copeland; W Frankel; B Chesebro
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice.

Authors:  K J Hasenkrug
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  A new transmissible AIDS-like disease in mice induced by alloimmune stimuli.

Authors:  V S Ter-Grigorov; O Krifuks; E Liubashevsky; A Nyska; Z Trainin; V Toder
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

6.  Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection.

Authors:  A K Pilgrim; G Pantaleo; O J Cohen; L M Fink; J Y Zhou; J T Zhou; D P Bolognesi; A S Fauci; D C Montefiori
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

7.  Induction of interferon-gamma production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation.

Authors:  J Yang; T L Murphy; W Ouyang; K M Murphy
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

8.  Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses.

Authors:  T V Golovkina; I Piazzon; I Nepomnaschy; V Buggiano; M de Olano Vela; S R Ross
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.

Authors:  D C Montefiori; G Pantaleo; L M Fink; J T Zhou; J Y Zhou; M Bilska; G D Miralles; A S Fauci
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

10.  IL-12 is not required for induction of type 1 cytokine responses in viral infections.

Authors:  A Oxenius; U Karrer; R M Zinkernagel; H Hengartner
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

View more
  12 in total

1.  Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry.

Authors:  Melissa Kane; Laure K Case; Christine Wang; Leonid Yurkovetskiy; Stanislav Dikiy; Tatyana V Golovkina
Journal:  Immunity       Date:  2011-06-30       Impact factor: 31.745

2.  Antibody-mediated immune control of a retrovirus does not require the microbiota.

Authors:  Jessica Wilks; Helen Beilinson; Betty Theriault; Alexander Chervonsky; Tatyana Golovkina
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

3.  Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob.

Authors:  Lisa K Denzin; Aly A Khan; Francesca Virdis; Jessica Wilks; Melissa Kane; Helen A Beilinson; Stanislav Dikiy; Laure K Case; Derry Roopenian; Michele Witkowski; Alexander V Chervonsky; Tatyana V Golovkina
Journal:  Immunity       Date:  2017-08-15       Impact factor: 31.745

4.  Multigenic control and sex bias in host susceptibility to spore-induced pulmonary anthrax in mice.

Authors:  Jagjit S Yadav; Suman Pradhan; Renuka Kapoor; Hansraj Bangar; Benjamin B Burzynski; Daniel R Prows; Linda Levin
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

5.  A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses.

Authors:  Melissa Kane; Felicity Deiss; Alexander Chervonsky; Tatyana V Golovkina
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

6.  Vital role for CD8+ cells in controlling retroviral infections.

Authors:  Melissa Kane; Laure K Case; Tatyana V Golovkina
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

7.  Lessons Learned from Mouse Mammary Tumor Virus in Animal Models.

Authors:  Jaquelin P Dudley; Tatyana V Golovkina; Susan R Ross
Journal:  ILAR J       Date:  2016

8.  Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection.

Authors:  Chioma M Okeoma; Josiah Petersen; Susan R Ross
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

9.  Genetic Control of Neonatal Immune Tolerance to an Exogenous Retrovirus.

Authors:  Emily Cullum; Stanislav Dikiy; Helen A Beilinson; Melissa Kane; Alessandra Veinbachs; Vera M Beilinson; Lisa K Denzin; Alexander Chervonsky; Tatyana Golovkina
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

10.  MHC Class II Presentation Is Affected by Polymorphism in the H2-Ob Gene and Additional Loci.

Authors:  Emily Cullum; Austin M Graves; Vera L Tarakanova; Lisa K Denzin; Tatyana Golovkina
Journal:  J Immunol       Date:  2021-06-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.